Advancement in Infection Control of Opportunistic Pathogen (Aspergillus spp.): Adjunctive Agents

E-ISSN： 1873-4316|14|2|226-232

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.14, Iss.2, 2013-02, pp. : 226-232

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Temozolomide: lymphopenia leads to opportunistic infection

Inpharma, Vol. 1, Iss. 1424, 2004-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

New agents for the prevention of opportunistic infections in haematopoietic stem cell transplant recipients

By Zuccotti Gianna Strasfeld Lynne Weinstock David M

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 10, 2005-08 ,pp. : 1669-1679

Informa Healthcare

Access to resources Recommend Favorite

Etanercept: CNS Aspergillus fumigatus infection: case report

Reactions Weekly, Vol. 1, Iss. 1200, 2008-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Recent Advancement of Direct-acting Antiviral Agents (DAAs) in Hepatitis C Therapy

Mini Reviews in Medicinal Chemistry, Vol. 18, Iss. 7, 2018-03 ,pp. : 584-596

Bentham Science Publishers

Access to resources Recommend Favorite

Advancement of Targeted Ultrasound Contrast Agents and their Applications in Molecular Imaging and Targeted Therapy

Current Pharmaceutical Design, Vol. 19, Iss. 8, 2013-03 ,pp. : 1516-1527

Bentham Science Publishers

Access to resources Recommend Favorite